Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to $252.3 million.

  • Agios Pharmaceuticals' Change in Acquisitions & Divestments rose 6803.14% to $252.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 2625.62%. This contributed to the annual value of $1.0 billion for FY2025, which is 2625.62% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $252.3 million for Q4 2025, which was up 6803.14% from $272.1 million recorded in Q3 2025.
  • Agios Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $368.7 million during Q1 2024, with a 5-year trough of $134.0 million in Q1 2021.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $209.3 million (2021), whereas its average is $225.1 million.
  • Per our database at Business Quant, Agios Pharmaceuticals' Change in Acquisitions & Divestments soared by 14784.13% in 2022 and then crashed by 5505.93% in 2023.
  • Over the past 5 years, Agios Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $336.9 million in 2021, then plummeted by 40.97% to $198.9 million in 2022, then dropped by 6.38% to $186.2 million in 2023, then fell by 19.36% to $150.1 million in 2024, then soared by 68.03% to $252.3 million in 2025.
  • Its Change in Acquisitions & Divestments was $252.3 million in Q4 2025, compared to $272.1 million in Q3 2025 and $220.6 million in Q2 2025.